BackgroundEpidermis-specific type I keratin involved in wound healing. Involved in the activation of follicular keratinocytes after wounding, while it does not play a major role in keratinocyte proliferation or migration. Participates in the regulation of epithelial migration by inhibiting the activity of SRC during wound repair.
DescriptionKRT6A Recombinant Monoclonal Antibody [21E2]. Unconjugated. Raised in: HEK293F Cell.
FormulationBuffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
SpecificityHuman
IsotypeRabbit IgG
Uniprot IDP02538
PurificationAffinity-chromatography
ImmunogenA synthesized peptide derived from Human KRT6A
StorageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Alternative NamesKeratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5), KRT6A, K6A KRT6D
ApplicationELISA, IF, FC; Recommended dilution: IF:1:50-1:200, FC:1:50-1:200